Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
By J. Ragaz, I. Olivotto, J. Spinelli, N. Phillips, S. Jackson, K. Wilson, M. Knowling, C. Coppin, L. Weir, K. Gelmon and 4 more. Journal of the National Cancer Institute, 2005
925 citations recorded by the source corpus.
Subfields: Cancer Research, Pathology and Forensic Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/ddbfdae673670b7cfa48d1e98315f87a4908e4cd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Pathology and Forensic Medicine
Citations in the corpus
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies (2010, methodology): “UBCBCT Canada Hospital-based Women with stage I to III breast cancer who participated in four different British Columbia Cancer Agency clinical trials between 1970 and 1990 and all received chemotherapy 22–90 [28,29]”
- Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. (2005, background): “The British Columbia study was updated at a median of 20 years and concluded that for patients with high-risk breast cancer radiation therapy and adjuvant chemotherapy yielded better survival than chemotherapy alone [54].”